Case Based Panel Discussion - Stage 3 NSCLC Patient with PDL1 Score of 0, Is Immunotherapy Beneficial?

Video
Dr. Jack West recently had the privilege to spend time with Drs. Millie Das and Matthew Gubens for a series of case-based discussions regarding unresectable NSCLC.

Dr. Millie Das specializes in the treatment of thoracic malignancies. She sees and treats patients both at the Stanford Cancer Center and at the Palo Alto VA Hospital. She is Chief of Oncology at the Palo Alto VA and also leads the VA thoracic tumor board on a biweekly basis.

Case Based Panel Discussion - Stage 3 NSCLC Treatment Standard and the Risk of Potential Pneumonitis

Video
Dr. Jack West recently had the privilege to spend time with Drs. Millie Das and Matthew Gubens for a series of case-based discussions regarding unresectable NSCLC.

Dr. Millie Das specializes in the treatment of thoracic malignancies. She sees and treats patients both at the Stanford Cancer Center and at the Palo Alto VA Hospital. She is Chief of Oncology at the Palo Alto VA and also leads the VA thoracic tumor board on a biweekly basis.

Case Based Panel Discussion Stage 3 NSCLC - Does Timing of Treatment Make a Difference in Response

Video
Dr. Jack West recently had the privilege to spend time with Drs. Millie Das and Matthew Gubens for a series of case-based discussions regarding unresectable NSCLC.

Dr. Millie Das specializes in the treatment of thoracic malignancies. She sees and treats patients both at the Stanford Cancer Center and at the Palo Alto VA Hospital. She is Chief of Oncology at the Palo Alto VA and also leads the VA thoracic tumor board on a biweekly basis.

Case Based Panel Discussion - Unresectable NSCLC, In a Frail Patient with Competing Risks, Is the Standard Treatment the Best Approach?

Video
Dr. Jack West recently had the privilege to spend time with Drs. Millie Das and Matthew Gubens for a series of case-based discussions regarding unresectable NSCLC .   

Dr. Millie Das specializes in the treatment of thoracic malignancies. She sees and treats patients both at the Stanford Cancer Center and at the Palo Alto VA Hospital. She is Chief of Oncology at the Palo Alto VA and also leads the VA thoracic tumor board on a biweekly basis.

Supportive Care Video Series: Pancreatic Enzyme Replacement Therapy, or PERT

Video
GRACE is very excited to bring to you more videos from our program, Supportive Care in Cancer Treatment.

Arjun Gupta, MD is the host of this video series, Supportive Care in Cancer Treatment. In this video, Dr. Gupta speaks with Christi M. Walsh, MSN, CRNP, with Johns Hopkins University in Baltimore, MD.

Christi Walsh and Dr. Gupta discuss Pancreatic Enzyme Replacement Therapy, or PERT.

Supportive Care Video Series - "Chemobrain" or Attention, Thinking or Memory Problems for Patients with Cancer

Video
We are very excited to bring to you this new program on supportive care in cancer treatment.

In this video, our host Dr. Arjun Gupta speaks with his guest, Lysa Buonanno, who is a lung cancer patient and patient advocate. Lysa and Dr. Gupta discuss the often poorly understood subject of 'chemobrain', or attention, thinking or memory problems in patients with cancer.

Case Based Panel Discussion - Unresectable NSCLC, Should Molecular Tests be Considered, and Would Outcome Effect Treatment Decisions?

Video
Dr. Jack West recently had the privilege to spend time with Drs. Millie Das and Matthew Gubens for a series of case-based discussions regarding unresectable NSCLC .   

Dr. Millie Das specializes in the treatment of thoracic malignancies. She sees and treats patients both at the Stanford Cancer Center and at the Palo Alto VA Hospital. She is Chief of Oncology at the Palo Alto VA and also leads the VA thoracic tumor board on a biweekly basis.

GRACE Podcasts Now Available!

Article

Prefer to listen to our amazing cancer education information while on the go?


We've got you covered with our new GRACE Podcast Program!

Listen on your favorite podcast platform like soundcloud or spreaker, search for cancerGRACE and subscribe! Look for new content every Wednesday throughout the year! 

 

Subscribe to English